AMW GmbH from Warngau continues to grow and founds an advisory board
Meanwhile more than 100 employees are employed at the pharmaceutical companyin Warngau. The specialy pharmaceuticalwas able to develop a generic drug for the contraception ring Nuvaring of MSD to market maturityin addition to the implants Goserelin and Leuprorelin as well as patches Buprenorphin and Rivastigmin,. With this product, AMW is setting new standards in contraception. Furthermorenew products are under development. In order to position itself even better scientifically and technically, AMW founds an advisory board consisting of Dr. Georg Ingram, Dr. Dirk Schrader and Prof. Dr. Gerhard Winter.
read more